Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Understanding these research-backed protocols helps inform safe, effective therapeutic approaches under medical supervision
The Fat Loss Mechanism The proposed fat loss mechanism of 5-amino-1MQ operates through several interrelated effects: NNMT inhibition preserves SAM and NAD+ pools Increased NAD+ supports sirtuin activity and mitochondrial function Reduced lipogenesis adipocyte fatty acid synthesis is decreased Enhanced adipocyte metabolism improved adipose tissue function Selective effect on adipocytes relative sparing of other tissues Preclinical studies have shown that 5-amino-1MQ treatment in mice produces: Reduced body fat mass Improved insulin sensitivity Preserved lean mass Favorable effects on liver fat in diet-induced obesity models The Human Clinical Trials Picture As of 2026, human clinical trial activity for 5-amino-1MQ is emerging but not yet mature
Adults generally require around 1.5 micrograms per day and pregnant or breastfeeding women require up to 2.8 micrograms a day
B12 injections have been shown to improve brain function and sharpen cognitive performance
Randomization: AOD-9604 at doses 0.25, 0.5, 1.0 mg daily SC vs placebo
Target the joint
